RecruitingPhase 3Drug trialA Study of Brenipatide in Participants With Alcohol Use DisorderThe purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with Alcohol Use Disorder (AUD) and hazardous alcohol use. Participation in this study will last approximately 56 weeks.